The prognostic value of the tumour-stroma ratio in invasive breast carcinoma

被引:0
|
作者
Mesker, W. E. [1 ]
Vangangelt, K. [1 ]
Tollenaar, L. [1 ]
van Pelt, G. [1 ]
Dekker, T. [1 ]
Kuppen, P. [1 ]
Tollenaar, R. [1 ]
机构
[1] Leiden Univ, Med Ctr, Surg, Leiden, Netherlands
关键词
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
PS-01-018
引用
收藏
页码:S52 / S52
页数:1
相关论文
共 50 条
  • [41] The relationship between the tumour-stroma percentage, clinicopathological characteristics and outcome in patients with invasive ductal breast cancer
    Gujam, F.
    Edwards, J.
    Mohammed, Z.
    Going, J.
    McMillan, D.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S189 - S189
  • [42] Correlation of the tumour-stroma ratio with diffusion weighted MRI in rectal cancer
    Zunder, Stephanie M.
    Perez-Lopez, Raquel
    de Kok, Bente M.
    Vittoria Raciti, Maria
    van Pelt, Gabi W.
    Dienstmann, Rodrigo
    Garcia-Ruiz, Alonso
    Meijer, C. Arnoud
    Gelderblom, Hans
    Tollenaar, Rob A.
    Nuciforo, Paolo
    Wasser, Martin N.
    Mesker, Wilma E.
    EUROPEAN JOURNAL OF RADIOLOGY, 2020, 133
  • [43] Tumour-stroma ratio (TSR) in breast cancer: comparison of scoring core biopsies versus resection specimens
    Karancsi, Zsofia
    Hagenaars, Sophie C.
    Nemeth, Kristof
    Mesker, Wilma E.
    Tokes, Anna Maria
    Kulka, Janina
    VIRCHOWS ARCHIV, 2024, 485 (04) : 703 - 716
  • [44] Toward a quantitative method for estimating tumour-stroma ratio in breast cancer using polarized light microscopy
    Sprenger, Jillian
    Murray, Ciara
    Lad, Jigar
    Jones, Blake
    Thomas, Georgia
    Nofech-Mozes, Sharon
    Khorasani, Mohammadali
    Vitkin, Alex
    BIOMEDICAL OPTICS EXPRESS, 2021, 12 (06): : 3241 - 3252
  • [45] The tumour-stroma ratio as an additional parameter to the TNM classification: The UNITED study
    Mesker, W.
    Smit, M.
    van Pelt, G.
    Gelderblom, H.
    van Krieken, H.
    Tollenaar, R.
    ANNALS OF ONCOLOGY, 2020, 31 : S222 - S223
  • [46] The tumour-stroma ratio as predictive aid towards a biopsy-based treatment strategy in rectal carcinoma
    Polack, Meaghan
    van Pelt, Gabi W.
    van den Heuvel, Davita H.
    Klein-Kranenbarg, Elma Meershoek
    Roodvoets, Annet G. H.
    Putter, Hein
    Crobach, Augustinus S. L. P.
    Nagtegaal, Iris D.
    Peeters, Koen C. M. J.
    Tollenaar, Rob A. E. M.
    van Krieken, J. Han J. M.
    Mesker, Wilma E.
    HISTOPATHOLOGY, 2025,
  • [47] Tumour-stroma ratio has poor prognostic value in nonpedunculated T1 colorectal cancer: A multicentre case-cohort study
    Dang, Hao
    van Pelt, Gabi W.
    Haasnoot, Krijn J. C.
    Backes, Yara
    Elias, Sjoerd G.
    Seerden, Tom C. J.
    Schwartz, Matthijs P.
    Spanier, Bernhard W. M.
    de Vos tot Nederveen Cappel, Wouter H.
    van Bergeijk, Jeroen D.
    Kessels, Koen
    Geesing, Joost M. J.
    Groen, John N.
    ter Borg, Frank
    Wolfhagen, Frank H. J.
    Seldenrijk, Cornelis A.
    Raicu, Mihaela G.
    Milne, Anya N.
    van Lent, Anja U. G.
    Brosens, Lodewijk A. A.
    Johan A. Offerhaus, G.
    Siersema, Peter D.
    Tollenaar, Rob A. E. M.
    Hardwick, James C. H.
    Hawinkels, Lukas J. A. C.
    Moons, Leon M. G.
    Lacle, Miangela M.
    Mesker, Wilma E.
    Boonstra, Jurjen J.
    UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2021, 9 (04) : 478 - 485
  • [48] Tumour-stroma interactions in urothelial cancer
    Hatina, J.
    Kripnerova, M.
    Tukova, J.
    Sramek, J.
    Dvorak, P.
    Pesta, M.
    Dobra, J.
    Babuska, V.
    Racek, J.
    Sobol, M.
    Philimonenko, A.
    Hozak, P.
    Czuba, Z.
    Schulz, W. A.
    Strell, C.
    Grimm, S.
    Jennek, S.
    Friedrich, K. -H.
    UROLOGE, 2015, 54 (04): : 516 - 525
  • [49] High tumour-stroma ratio in oestrogen receptor-positive breast cancer is correlated to poor histopathological parameters
    Sarra, G.
    Ben Slama, S.
    Ben Othman, N.
    Lahmar, A.
    Bacha, D.
    VIRCHOWS ARCHIV, 2021, 479 (SUPPL 1) : S73 - S73
  • [50] Tumour budding and tumour–stroma ratio in hepatocellular carcinoma
    Valtteri Kairaluoma
    Niko Kemi
    Vesa-Matti Pohjanen
    Juha Saarnio
    Olli Helminen
    British Journal of Cancer, 2020, 123 : 38 - 45